Details of the Drug

General Information of Drug (ID: DMP2FP3)

Drug Name

CB4211

Synonyms

2-(4-Bromophenyl)propan-2-amine; 2-(4-bromophenyl)propan-2-amine; 17797-12-5; 1-(4-BROMOPHENYL)-1-METHYLETHYLAMINE; 4-Bromo-alpha,alpha-dimethylbenzylamine; 1-(4-bromo-phenyl)-1-methyl-ethylamine; 4-bromocumylamine; AC1Q1NMD; SCHEMBL756324; AMOT0675; CTK6A4853; DTXSID10629746; MolPort-009-685-068; IQKKTIWXHJDLFL-UHFFFAOYSA-N; 2-(4-Bromophenyl)-2-propanamine; 5952AD; ZINC19673395; AKOS004119571; MCULE-7805384456; AN-3637; CB-4211; QC-8287; AB29702; KS-000009M3; 1-(4-Bromophenyl)-1-methyl-ethylamine; BS-13505; AJ-74161; SC-44400; 2-(4-BROMOPHENYL)PROP-2-YLAMINE; 2-(4-B

Indication

Disease Entry	ICD 11	Status	REF
Non-alcoholic steatohepatitis	DB92.1	Phase 1	[1]
------------------------------------------------------------------------------------

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C9H12BrN
Canonical SMILES: CC(C)(C1=CC=C(C=C1)Br)N
InChI: 1S/C9H12BrN/c1-9(2,11)7-3-5-8(10)6-4-7/h3-6H,11H2,1-2H3
InChIKey: IQKKTIWXHJDLFL-UHFFFAOYSA-N

Cross-matching ID

PubChem CID: 23009116
CAS Number: 17797-12-5
TTD ID: D09QWN

References

1	Constrained peptides' time to shine. Nat Rev Drug Discov. 2018 Jul 30;17(8):531-533.